Cboe UK EUR

Pharma Mar, S.A. (PHME.XC)

Compare
68.82 0.00 (0.00%)
As of October 16 at 3:10:28 PM GMT+1. Market Open.

Valuation Measures

Annual
Monthly
Currency in EUR
Download
Current9/30/20246/30/20243/31/202412/31/20239/30/2023
Market Cap 1.36B 863.55M 555.41M 503.41M 722.40M 571.51M
Enterprise Value 1.26B 767.78M 435.95M 384.52M 591.63M 430.30M
Trailing P/E 1.67k -- -- 709.00 -- --
Forward P/E -- -- -- -- -- --
PEG Ratio (5yr expected) -- -- -- -- -- --
Price/Sales 7.16 -- -- 4.82 -- --
Price/Book 6.56 -- -- 3.85 -- --
Enterprise Value/Revenue 7.53 -- -- 2.43 14.60 11.49
Enterprise Value/EBITDA 235.45 -- -- 84.53 -868.76 438.18
9/30/2023 - 11/3/2015

Upgrade to begin using 40 years of earnings data and get so much more.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Upgrade

Financial Highlights

Fiscal Year

Fiscal Year Ends 12/31/2023
Most Recent Quarter (mrq) 9/30/2024

Profitability

Profit Margin 0.37%
Operating Margin (ttm) 12.00%

Management Effectiveness

Return on Assets (ttm) -0.65%
Return on Equity (ttm) 0.32%

Income Statement

Revenue (ttm) 167M
Revenue Per Share (ttm) 9.52
Quarterly Revenue Growth (yoy) 21.90%
Gross Profit (ttm) --
EBITDA -477k
Net Income Avi to Common (ttm) 622k
Diluted EPS (ttm) 0.04
Quarterly Earnings Growth (yoy) 156.70%

Balance Sheet

Total Cash (mrq) 144.39M
Total Cash Per Share (mrq) 8.23
Total Debt (mrq) 53.48M
Total Debt/Equity (mrq) 29.35%
Current Ratio (mrq) 2.66
Book Value Per Share (mrq) 10.39

Cash Flow Statement

Operating Cash Flow (ttm) 1.65M
Levered Free Cash Flow (ttm) -17.05M

Trading Information

Stock Price History

Beta (5Y Monthly) 0.04
52 Week Range 3 110.35%
S&P 500 52-Week Change 3 24.21%
52 Week High 3 68.82
52 Week Low 3 32.72
50-Day Moving Average 3 67.97
200-Day Moving Average 3 49.12

Share Statistics

Avg Vol (3 month) 3 8
Avg Vol (10 day) 3 --
Shares Outstanding 5 17.38M
Implied Shares Outstanding 6 20.39M
Float 8 13.63M
% Held by Insiders 1 26.80%
% Held by Institutions 1 7.38%
Shares Short 4 --
Short Ratio 4 --
Short % of Float 4 --
Short % of Shares Outstanding 4 --
Shares Short (prior month ) 4 --

Dividends & Splits

Forward Annual Dividend Rate 4 0.65
Forward Annual Dividend Yield 4 0.94%
Trailing Annual Dividend Rate 3 0.65
Trailing Annual Dividend Yield 3 0.94%
5 Year Average Dividend Yield 4 --
Payout Ratio 4 1,580.97%
Dividend Date 3 --
Ex-Dividend Date 4 6/12/2024
Last Split Factor 2 1:12
Last Split Date 3 7/22/2020

Footnotes

  • 1 Data provided by Refinitiv.
  • 2 Data provided by EDGAR Online.
  • 3 Data derived from multiple sources or calculated by Yahoo Finance.
  • 4 Data provided by Morningstar, Inc.
  • 5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
  • 6 Implied Shares Outstanding of common equity, assuming the conversion of all convertible subsidiary equity into common.
  • 7 EBITDA is calculated by S&P Global Market Intelligence using methodology that may differ from that used by a company in its reporting.
  • 8 A company's float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which may not be publicly traded.

Abbreviation Guide

  • mrq = Most Recent Quarter
  • ttm = Trailing Twelve Months
  • yoy = Year Over Year
  • lfy = Last Fiscal Year
  • fye = Fiscal Year Ending